
Medyssey tops $10 mil. in global sales as 3D-printed spinal implants surge
Medyssey pulled in $10.63 million in overseas revenue in 2024, up 10 percent from the previous year—its strongest performance since Dong Wha Pharm, Korea’s first pharmaceutical company, acquired the spinal implant maker in 2020 for 20 billion won ($13.7 …